Latest Artificial organs Stories
SAN DIEGO, June 28, 2011 /PRNewswire/ -- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery,( )survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.
The incidence of internal bleeding was higher in the most commonly implanted heart device than in an earlier model.
PLEASANTON, Calif., May 6, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2011 Health Care Conference on Wednesday, May 11. David V.
Nancy Young, MD, founder and medical director of Children's Memorial Hospitalâ€™s cochlear implant program, is one of a handful of specialists nationwide to have performed her 1000th cochlear implant on a child.
PLEASANTON, Calif., May 3, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today commented on an article published in the Journal of the American College of Cardiology (JACC) examining outcomes from a bridge-to-transplantation (BTT) post-approval study featuring the company's HeartMate IIÂ® LVAS (Left Ventricular Assist System).
LOS ANGELES, March 16, 2011 /PRNewswire/ -- A deaf man takes a chance on a risky surgery in hopes of hearing for the first time in his life.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
More Images (1 images) »